Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
5
|
| pubmed:dateCreated |
1997-8-21
|
| pubmed:abstractText |
Lamotrigine (LTG), one of the newly developed antiepileptic drugs, is efficacious in treating both partial and generalized seizure disorders including Lennox-Gastaut syndrome. Its effect as an add-on therapy was evaluated in 41 adult Chinese patients with refractory epilepsy. Five of the patients were Lennox-Gastaut syndrome and 36 patients had partial epilepsy.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
May
|
| pubmed:issn |
0578-1337
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
59
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
303-7
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:9248123-Adolescent,
pubmed-meshheading:9248123-Adult,
pubmed-meshheading:9248123-Anticonvulsants,
pubmed-meshheading:9248123-Epilepsy,
pubmed-meshheading:9248123-Female,
pubmed-meshheading:9248123-Humans,
pubmed-meshheading:9248123-Male,
pubmed-meshheading:9248123-Middle Aged,
pubmed-meshheading:9248123-Triazines
|
| pubmed:year |
1997
|
| pubmed:articleTitle |
Lamotrigine as add-on therapy in adult patients with refractory epilepsy.
|
| pubmed:affiliation |
Department of Neurology, Veterans General Hospital-Taipei, Taiwan, R.O.C.
|
| pubmed:publicationType |
Journal Article
|